A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 28, 2020

Primary Completion Date

June 21, 2021

Study Completion Date

June 21, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

E6742

E6742 tablets.

DRUG

Placebo

E6742-matched placebo tablets.

Trial Locations (1)

Eisai Trial Site #1, Bunkyō-Ku

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT04683185 - A Study to Assess the Safety and Tolerability of E6742 in Japanese Healthy Adult Participants | Biotech Hunter | Biotech Hunter